CS
MRSN

Candriam SCA’s Mersana Therapeutics MRSN Stock Holding History

Candriam SCA’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-96,619
Closed -$7.95M – 681
2023
Q2 		$7.95M Sell
96,619
-21,895
-18% -$3.2M 0.06% 274
2023
Q1 		$11.2M Buy
118,514
+10,800
+10% +$1.52M 0.08% 243
2022
Q4 		$15.8M Buy
107,714
+7,800
+8% +$1.32M 0.11% 197
2022
Q3 		$16.9M Buy
99,914
+20,292
+25% +$3.3M 0.12% 187
2022
Q2 		$9.2M Buy
79,622
+5,829
+8% +$548K 0.08% 237
2022
Q1 		$7.36M Sell
73,793
-7,123
-9% -$832K 0.05% 295
2021
Q4 		$12.6M Hold
80,916
– – 0.08% 231
2021
Q3 		$19.1M Buy
80,916
+2,000
+3% +$584K 0.13% 183
2021
Q2 		$26.8M Buy
78,916
+34,029
+76% +$12.9M 0.18% 131
2021
Q1 		$28.7M Buy
44,887
+1
+0% +$485 0.24% 110
2020
Q4 		$29.9M Buy
44,886
+21,378
+91% +$11.9M 0.24% 110
2020
Q3 		$10.9M Sell
23,508
-322
-1% -$163K 0.1% 217
2020
Q2 		$13.9M Buy
+23,830
New +$8.14M 0.15% 166
2018
Q2 		– Sell
-1,440
Closed -$568K – 814
2018
Q1 		$568K Buy
1,440
+960
+200% +$379K 0.01% 662
2017
Q4 		$197K Buy
+480
New +$209K ﹤0.01% 742

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return